Dangerous small B-cell clones
Top Cited Papers
- 15 October 2006
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 108 (8), 2520-2530
- https://doi.org/10.1182/blood-2006-03-001164
Abstract
The detection of a monoclonal immunoglobulin in serum or urine usually raises concerns about the size of the underlying B-cell-derived clone and possible systemic effects caused by its expansion. However, a small clone can synthesize a very toxic protein, producing devastating systemic damage and protean clinical presentations. The resulting “monoclonal component-related diseases,” although difficult to diagnose, may be progressive and even fatal. The monoclonal protein can aggregate and deposit systemically as occurs in light-chain amyloidosis, monoclonal immunoglobulin deposition disease, crystal-storing histiocytosis, and monoclonal cryoglobulinemia. Alternatively, some monoclonal proteins possess antibody activity toward autogenous antigens and cause chronic cold agglutinin disease, mixed cryoglobulinemia, and peripheral neuropathies. Other humoral mediators may contribute to neuropathy in variant disorders such as the POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) syndrome. The clone synthesizing the noxious monoclonal proteins is often small, and sensitive techniques may be required to detect these immunoglobulins. A delay in diagnosis can allow irreversible organ damage and dramatically shorten survival. Prompt recognition of suggestive signs and symptoms should trigger a thorough diagnostic approach to reach the correct diagnosis quickly, because this is the key to effective therapy. Although the treatment of these conditions is not optimal, significant advances have been made, improving the duration and quality of life.Keywords
This publication has 99 references indexed in Scilit:
- AmyloidosisBest Practice & Research Clinical Haematology, 2005
- Multicentre versus single centre approach to rare diseases: The model of systemic light chain amyloidosisAmyloid, 2005
- Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot studyJournal of Hepatology, 2005
- Localized amyloidosis: A survey of 35 French casesAmyloid, 2005
- Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rateBone Marrow Transplantation, 2004
- Efficacy and safety of rituximab in type II mixed cryoglobulinemiaBlood, 2003
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Cryocrystalglobulinemia as a cause of systemic vasculopathy and widespread erosive arthropathyArthritis & Rheumatism, 1996
- Crystalglobulinemia syndrome. A manifestation of multiple myelomaCancer, 1993
- KAPPA‐TYPE LIGHT CHAIN CRYSTAL STORAGE HISTIOCYTOSISActa Pathologica Japonica, 1978